Approval · Notice of Compliance 5301 · 1995

CLOPIXOL: Notice of Compliance 5301

Issued April 24, 1995

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 5301
Date: April 24, 1995
Company: Marion Merrell Dow (Canada) Inc.Laval, Quebec, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: New Active Substance (NAS)
Therapeutic class: Antipsychotic agent

Products in this notice

Brand	DIN	Status today
CLOPIXOL	02162903	Cancelled Post Market
CLOPIXOL	02162911	Cancelled Post Market
CLOPIXOL	02162938	Cancelled Post Market

Medicinal ingredients

ZUCLOPENTHIXOL HYDROCHLORIDE 10 MG per TAB
ZUCLOPENTHIXOL HYDROCHLORIDE 25 MG per TAB
ZUCLOPENTHIXOL HYDROCHLORIDE 40 MG per TAB